Exam 3 Flashcards

1
Q

Which NOAC causes increased GI bleeding?

A

apixaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which NOAC has an antidote and what is it called?

A

dabigatran, antidote is idarucizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the investigational NOAC antidotes?

A

andexanet alfa

ciraparantag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which investigational NOAC is factor Xa specific and which one is universal?

A

Xa: andexanet alfa
universal: ciraparantag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which NOACs do not use starter injectable anticoag?

A

rivaroxaban

apixaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the inhibitors of NOAC DDI?

A

dronaderone
ketoconazole
diltiazem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the inducers of NOAC DDI?

A

rifampin

St. John’s wort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which NOAC is heavily reliant on renal CL?

A

dabigatran, but all are renally metabbed to some extent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which NOAC is dialyzable?

A

dabigatran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which NOAC needs to be taken with food?

A

rivaroxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which NOACs require an injectable lead-in anticoag?

A

dabigatran

edoxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which NOACs are indicated for orthopedic surgery?

A

rivaroxaban

apixaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the dosing of apixaban in prevention of thrombus in atrial fibrillation?

A

5 mg BID

IF two or more of following 2.5 mg BID: ≥ 80 years, ≤ 60 kg, CrCL ≥ 1.5 mg/dL, on strong dual inhibitors of 3A4 or p-gp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the dosing of dabigatran in prevention of thrombus in atrial fibrillation withOUT p-gp inhibitors?

A

CrCL > 30 mL/min: 150 mg BID

CrCL 15-30 mL/min 75 mg BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the dosing of dabigatran in prevention of VTE in a-fib WITH p-gp inhibitors?

A

CrCL 30-50 mL/min: 75 mg BID

CrCL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the dosing of edoxaban in prevention of VTE in a-fib?

A

CrCL 50-95 mL/min: 60 mg QD
CrCL 15-50 mL/min: 30 mg QD
CrCL > 95 mL/min: contraindicated

17
Q

What is the dosing of rivaroxaban in prevention of VTE in a-fib at CrCL ≥ 50 mL/min?

A

20 mg QD with evening meal

18
Q

What is the dosing of rivaroxaban in prevention of VTE in a-fib at CrCL 15-50 mL/min?

A

15 mg QD with evening meal

19
Q

What is the dosing of rivaroxaban in prevention of VTE in a-fib at CrCL

A

not recommended

20
Q

What is the dosing of apixaban in VTE prevention in hip or knee replacement?

A

2.5 mg BID

21
Q

What is the dosing of apixaban in treatment of VTE?

A

10 mg BID x7D then 5 mg BID

after 6 months: 2.5 mg BID

22
Q

What is the dosing of dabigatran in treatment of VTE withOUT p-gp inhibitors at CrCL > 30 mL/min?

A

150 mg BID after 5-10 days of parenteral anticoag

23
Q
A

not recommended